PPL
54
5
AN
47
3
TJX
43
3
HIG
54
2
JPM
59
3
ALLE
44
5
EQT
30
5
FOXA
63
3
CMS
57
3
APH
65
4
IPG
50
2
LB
45
15
EXPD
40
3
UNH
55
5
NWS
62
4
ROP
53
2
MSFT
46
2
DGX
36
3
DG
27
-2
CMA
53
3
PPL
54
5
AN
47
3
TJX
43
3
HIG
54
2
JPM
59
3
ALLE
44
5
EQT
30
5
FOXA
63
3
CMS
57
3
APH
65
4
IPG
50
2
LB
45
15
EXPD
40
3
UNH
55
5
NWS
62
4
ROP
53
2
MSFT
46
2
DGX
36
3
DG
27
-2
CMA
53
3
Financhill
Back

Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
33

GNMSF
Genmab AS

Last Price:
220.28
Seasonality Move:
-0.03%
Sell
27

ASND
Ascendis Pharma AS

Last Price:
127.98
Seasonality Move:
11.25%
Sell
33
Genmab AS (GNMSF) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GNMSF] share price is $220.28. The Score for GNMSF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNMSF Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $220.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GNMSF is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $128.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

GNMSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.23 Sell
Relative Strength Index (14 RSI): 41.2 Sell
Chaikin Money Flow: -949 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (222.46 - 235.62) Sell
Bollinger Bands (100): (236.16 - 272.06) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.75 Sell
Relative Strength Index (14 RSI): 46.53 Sell
Chaikin Money Flow: 189333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.62 - 137.64) Sell
Bollinger Bands (100): (125.03 - 141.83) Sell

GNMSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 223.15 Sell
20-day SMA: 227.14 Sell
50-day SMA: 245.41 Sell
200-day SMA: 270.4 Sell
8-day EMA: 223.07 Sell
20-day EMA: 227.93 Sell
50-day EMA: 240.13 Sell
200-day EMA: 271.79 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.38 Buy
20-day SMA: 128.13 Sell
50-day SMA: 133.2 Sell
200-day SMA: 137.43 Sell
8-day EMA: 126.59 Buy
20-day EMA: 129.14 Sell
50-day EMA: 132.14 Sell
200-day EMA: 130.84 Sell

Genmab AS Earnings Growth & GNMSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):